{
    "@context": {
        "geneontology": "http://www.geneontology.org/formats/oboInOwl#",
        "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
        "obo": "http://purl.obolibrary.org/obo/",
        "uniprot": "http://purl.uniprot.org/",
        "owl": "http://www.w3.org/2002/07/owl#",
        "concept": "https://data.omgeving.vlaanderen.be/id/concept/chemische_stof/",
        "chebi": "http://purl.obolibrary.org/obo/chebi/",
        "skos": "http://www.w3.org/2004/02/skos/core#",
        "dbo": "http://dbpedia.org/ontology/",
        "dbp": "http://dbpedia.org/property/",
        "altLabel": {
            "@id": "http://www.w3.org/2004/02/skos/core#altLabel",
            "@language": "en"
        },
        "graph": {
            "@id": "@graph"
        }
    },
    "@id": "concept:VHVPQPYKVGDNFY-ZPGVKDDISA-N",
    "@type": "skos:Concept",
    "dbo:formula": "C35H38Cl2N8O4",
    "dbo:inchi": "InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1",
    "dbo:smiles": "CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O",
    "dbp:inchikey": "VHVPQPYKVGDNFY-ZPGVKDDISA-N",
    "chebi:charge": "0",
    "skos:altLabel": [
        "2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",
        "Itraconazole",
        "Itrizole (TN)",
        "Oriconazole",
        "Sporanox (TN)"
    ],
    "skos:exactMatch": {
        "@id": "obo:CHEBI_6076"
    },
    "skos:note": "An N-arylpiperazine that is cis-ketoconazole in which the imidazol-1-yl group is replaced by a 1,2,4-triazol-1-yl group and in which the actyl group attached to the piperazine moiety is replaced by a p-[(+-)1-sec-butyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]phenyl group. A potent P-glycoprotein and CYP3A4 inhibitor, it is used as an antifungal drug for the treatment of various fungal infections, including aspergillosis, blastomycosis, candidiasis, chromoblastomycosis, coccidioidomycosis, cryptococcosis, histoplasmosis, and sporotrichosis.",
    "skos:semanticRelation": [
        {
            "@id": "obo:CHEBI_35618"
        },
        {
            "@id": "obo:CHEBI_35727"
        },
        {
            "@id": "obo:CHEBI_23697"
        },
        {
            "@id": "obo:CHEBI_59779"
        },
        {
            "@id": "obo:CHEBI_46848"
        },
        {
            "@id": "obo:CHEBI_87071"
        },
        {
            "@id": "obo:CHEBI_39430"
        },
        {
            "@id": "obo:CHEBI_87101"
        }
    ]
}